Clinical Trial Update: Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating clinical and immunological activity, safety and tolerability of different doses/formulations of AFFITOPE AD02 in early Alzheimer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AFFITOPE AD02 (AD02)

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED